Subclonal evolution and expansion of resistant cells is associated with recurrence in glioblastoma
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
Paired pre-treatment and recurrent mouse model tumors
应用场景：
创建时间：
2026-02-09
相关数据集
Glioblastoma stem cell (GSC) clones survived 500uM Temozolomide (TMZ) treatment. Homo sapiens
Comparison of parental GSC (GSC-parental) with treatment resistant GSC clones survived 500uM TMZ treatment (GSC-500uM TMZ) We used microarrays to identify defense profiles of GSC-500uM TMZ Overall des
NIAID Data Ecosystem80
Rational targeting of dynamic tumor subclones in relapsing human glioblastoma
Glioblastoma therapy relies on the alkylating drug temozolomide (TMZ) administered to irradiated patients post-neurosurgery, which increases overall survival but cannot prevent fatal disease relapse.
NIAID Data Ecosystem50
Establishment and characterization of a chemoresistant glioblastoma cell line from an Iraqi patient
Glioblastoma multiforme is a highly aggressive malignant primary brain tumor in humans, with poor prognosis. ANGM5 has been established from a cerebral glioblastoma multiforme in a 72-years-old Iraqi
NIAID Data Ecosystem40
Activation of STAT3 through SRC and EGFR Drives Resistance to a Mitotic Kinesin Inhibitor in Glioblastoma
The outcome for patients afflicted with glioblastoma (GBM), the most common and malignant of primary brain tumors in adults, has changed little despite decades of clinical, translational, and basic re
NIAID Data Ecosystem70
Additional file 10 of Drug resistant glioblastoma stem cells exhibit enriched stemness signatures and share extracellular matrix overexpression
Additional file 10. Differentially expressed genes. Complete list of the differentially expressed genes between the drug-resistant and drug-sensitive GSC cultures.
Figshare2025-10-27 更新50
